Skip to main content
. 2020 Jan 31;11:93. doi: 10.3389/fimmu.2020.00093

Table 1.

Clinical symptoms after subcutaneous administration of hBD2.

Test compound Dose level mg/kg Clinical signs on the day of dosing Necropsy
No clinical signs Pruritus Clinical signs Clinical signs at the end of the day of dosing Macroscopic findings
Vehicle 0 3/3 0/3 0/3 0/3 0/3
HBD2 0.5 3/3 0/3 0/3 0/3 0/3
10 0/3 3/3 3/3 0/3 0/3
40 0/3 3/3 3(severe)/3 0/3 0/3